Theory of mind in Parkinson’s disease: evidences in drug-naïve patients and longitudinal effects of dopaminergic therapy

被引:0
|
作者
Eleonora Del Prete
Pierpaolo Turcano
Elisa Unti
Giovanni Palermo
Cristina Pagni
Daniela Frosini
Ubaldo Bonuccelli
Roberto Ceravolo
机构
[1] University of Pisa,Department of Clinical and Experimental Medicine, Neurology Unit
[2] Mayo Clinic,Mayo Clinic Department of Neurology
[3] AOUP,Department of Medical, Specialities Neurology Unit
来源
Neurological Sciences | 2020年 / 41卷
关键词
Theory of mind; Parkinson’s disease; Dopaminergic therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Theory of mind (ToM) is the ability to attribute mental states to one self and others and to understand that others have beliefs different from one’s own. Different subcomponents of ToM have also been identified: cognitive and affective. Cognitive ToM refers to the capacity to infer others’ beliefs and intentions, while affective ToM implies the ability to appreciate others’ emotional states. The aim of this study was to explore ToM in drug-naïve Parkinson’s disease (PD) patients and to investigate the effects of chronic dopaminergic therapy on different subcomponents of ToM during a 3 months and 1 year of follow-up. We examined 16 PD patients in three conditions: before (un-medicated) and after dopaminergic therapy (medicated 3 months: T1 and medicated 1 year: T2). We also compared our PD’s ToM abilities with 11 healthy individuals. ToM was explored with 5 different tasks: Faux Pas Test, Picture Sequencing Task Capture Story, Emotion Attribution Task, Strange Stories Task, and Karolinska Directed Emotional Faces. Our study confirms that PD patients present deficits in cognitive components of ToM and preserved performances in the affective ones in early stages of disease. We also find a significant effect of dopaminergic therapy on ToM already after 3 months with a good persistency after 1 year of treatment.
引用
收藏
页码:2761 / 2766
页数:5
相关论文
共 50 条
  • [21] Structural MRI study of Pareidolia and Visual Hallucinations in Drug-Naïve Parkinson's disease
    Ozawa, Masakazu
    Shiraishi, Tomotaka
    Murakami, Hidetomo
    Yoshimaru, Daisuke
    Onda, Asako
    Matsuno, Hiromasa
    Komatsu, Teppei
    Sakuta, Kenichi
    Sakai, Kenichiro
    Umehara, Tadashi
    Mitsumura, Hidetaka
    Okano, Hirotaka James
    Iguchi, Yasuyuki
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] Serum uric acid is associated with apathy in early, drug-na⟨ve Parkinson's disease
    Picillo, Marina
    Santangelo, Gabriella
    Moccia, Marcello
    Erro, Roberto
    Amboni, Marianna
    Prestipino, Elio
    Longo, Katia
    Vitale, Carmine
    Spina, Emanuele
    Orefice, Giuseppe
    Barone, Paolo
    Pellecchia, Maria Teresa
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (04) : 371 - 377
  • [23] Neurovascular coupling alteration in drug-naïve Parkinson's disease: The underlying molecular mechanisms and levodopa's restoration effects
    Wu, Chenqing
    Wu, Haoting
    Zhou, Cheng
    Guan, Xiaojun
    Guo, Tao
    Wu, Jingjing
    Chen, Jingwen
    Wen, Jiaqi
    Qin, Jianmei
    Tan, Sijia
    Duanmu, Xiaojie
    Yuan, Weijin
    Zheng, Qianshi
    Zhang, Baorong
    Xu, Xiaojun
    Zhang, Minming
    NEUROBIOLOGY OF DISEASE, 2024, 191
  • [24] Altered dynamic functional network connectivity in drug-naïve Parkinson's disease patients with excessive daytime sleepiness
    Tan, Zhiyi
    Zeng, Qiaoling
    Hu, Xuehan
    Di, Duoduo
    Chen, Lele
    Lin, Zhijian
    Cheng, Guanxun
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [25] Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease
    Bereau, Matthieu
    Castrioto, Anna
    Servant, Mathieu
    Lhommee, Eugenie
    Desmarets, Maxime
    Bichon, Amelie
    Pelissier, Pierre
    Schmitt, Emmanuelle
    Klinger, Helene
    Longato, Nadine
    Phillipps, Clelie
    Wirth, Thomas
    Fraix, Valerie
    Benatru, Isabelle
    Durif, Franck
    Azulay, Jean-Philippe
    Moro, Elena
    Broussolle, Emmanuel
    Thobois, Stephane
    Tranchant, Christine
    Krack, Paul
    Anheim, Mathieu
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [26] Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease
    Cecilia Quarracino
    Matilde Otero-Losada
    Francisco Capani
    Santiago Pérez-Lloret
    Clinical Autonomic Research, 2020, 30 : 265 - 271
  • [27] Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson’s disease
    Matthieu Béreau
    Anna Castrioto
    Mathieu Servant
    Eugénie Lhommée
    Maxime Desmarets
    Amélie Bichon
    Pierre Pélissier
    Emmanuelle Schmitt
    Hélène Klinger
    Nadine Longato
    Clélie Phillipps
    Thomas Wirth
    Valérie Fraix
    Isabelle Benatru
    Franck Durif
    Jean-Philippe Azulay
    Elena Moro
    Emmanuel Broussolle
    Stéphane Thobois
    Christine Tranchant
    Paul Krack
    Mathieu Anheim
    Scientific Reports, 13
  • [28] Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease
    Marcello Moccia
    Sabina Pappatà
    Marina Picillo
    Roberto Erro
    Anna Rita Daniela Coda
    Katia Longo
    Carmine Vitale
    Marianna Amboni
    Arturo Brunetti
    Giuseppe Capo
    Marco Salvatore
    Paolo Barone
    Maria Teresa Pellecchia
    Journal of Neurology, 2014, 261 : 2112 - 2118
  • [29] Patterns of striatal and cerebellar functional connectivity in early-stage drug-naïve patients with Parkinson’s disease subtypes
    Yanbing Hou
    Ruwei Ou
    Jing Yang
    Wei Song
    Qiyong Gong
    Huifang Shang
    Neuroradiology, 2018, 60 : 1323 - 1333
  • [30] Prevalence, risk factors, and clinical correlations of underweight in Chinese newly diagnosed and drug-naïve patients with Parkinson’s disease
    Qing Wu
    Ming Yu
    Jianfei Fu
    Meizhen Liu
    Neurological Sciences, 2021, 42 : 1097 - 1102